Dmitry Balyasny’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.6M Buy
463,700
+3,700
+0.8% +$550K 0.09% 259
2026
Q1
$67.4M Sell
460,000
-296,000
-39% -$45.7M 0.09% 260
2025
Q4
$117M Sell
756,000
-589,100
-44% -$88.2M 0.15% 150
2025
Q3
$187M Buy
1,345,100
+336,800
+33% +$45.6M 0.24% 76
2025
Q2
$136M Sell
1,008,300
-325,000
-24% -$43.9M 0.2% 98
2025
Q1
$195M Sell
1,333,300
-47,000
-3% -$6.83M 0.32% 45
2024
Q4
$190M Buy
1,380,300
+731,800
+113% +$107M 0.28% 63
2024
Q3
$99.9M Buy
648,500
+375,800
+138% +$57M 0.16% 128
2024
Q2
$39.7M Sell
272,700
-9,600
-3% -$1.38M 0.07% 362
2024
Q1
$41.7M Buy
282,300
+102,800
+57% +$14.7M 0.07% 363
2023
Q4
$24.5M Buy
179,500
+49,200
+38% +$6.4M 0.05% 524
2023
Q3
$16.8M Sell
130,300
-339,700
-72% -$45.1M 0.03% 640
2023
Q2
$62.4M Sell
470,000
-880,100
-65% -$116M 0.14% 201
2023
Q1
$175M Sell
1,350,100
-652,400
-33% -$85.2M 0.44% 23
2022
Q4
$272M Buy
2,002,500
+1,402,700
+234% +$186M 0.74% 4
2022
Q3
$72.6M Buy
599,800
+49,400
+9% +$6.36M 0.22% 94
2022
Q2
$70.6M Buy
550,400
+330,400
+150% +$43.3M 0.23% 87
2022
Q1
$30.1M Buy
220,000
+60,000
+38% +$7.94M 0.1% 285
2021
Q4
$22.5M Buy
160,000
+10,000
+7% +$1.33M 0.08% 362
2021
Q3
$19.1M Buy
+150,000
New +$19.8M 0.08% 355
2021
Q1
Sell
-50,000
Closed -$5.67M 2123
2020
Q4
$5.67M Buy
+50,000
New +$5.46M 0.03% 598
2020
Q1
Sell
-100,000
Closed -$10.2M 1571
2019
Q4
$10.2M Sell
100,000
-200,000
-67% -$19.2M 0.06% 425
2019
Q3
$27M Sell
300,000
-150,000
-33% -$13.7M 0.19% 167
2019
Q2
$42.2M Buy
+450,000
New +$40.5M 0.27% 79
2018
Q1
Sell
-300,000
Closed -$24.8M 2372
2017
Q4
$24.8M Buy
300,000
+150,000
+100% +$12.4M 0.08% 337
2017
Q3
$12.3M Sell
150,000
-50,000
-25% -$4.02M 0.05% 438
2017
Q2
$15.8M Buy
+200,000
New +$15.2M 0.07% 388
2017
Q1
Sell
-200,000
Closed -$13.8M 1822
2016
Q4
$13.8M Buy
+200,000
New +$13.9M 0.07% 380
2015
Q4
Sell
-100,000
Closed -$6.62M 1486
2015
Q3
$6.62M Sell
100,000
-400,000
-80% -$29.2M 0.05% 448
2015
Q2
$37.2M Buy
500,000
+400,000
+400% +$29.6M 0.23% 112
2015
Q1
$7.25M Buy
+100,000
New +$7.13M 0.06% 404
2013
Q3
Sell
-400,000
Closed -$19M 737
2013
Q2
$19M Buy
+400,000
New +$19.2M 0.32% 69

Other funds holding XLV

Dmitry Balyasny's XLV Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2026: 35,892 shares worth $5.69M. The stake represents 0.01% of the portfolio and ranks #1317 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in XLV as recently as Q4 2025.

Dmitry Balyasny first reported a position in XLV in Q2 2013 and has held it in 25 quarters since. The position peaked at $55.3M in Q1 2023. 1,850 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Dmitry Balyasny held 35,892 shares of State Street Health Care Select Sector SPDR ETF worth $5.69M as of Q2 2026.
  • State Street Health Care Select Sector SPDR ETF was a new Dmitry Balyasny position in Q2 2026.
  • State Street Health Care Select Sector SPDR ETF made up 0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1317 holding.
  • Dmitry Balyasny first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 25 quarters since.
  • Dmitry Balyasny's State Street Health Care Select Sector SPDR ETF position peaked at $55.3M in Q1 2023.
  • 1,850 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.